Key result
Neutralizing and protective antibodies in measles are solely directed against the two surface glycoproteins, hemagglutinin and fusion protein.
Neutralizing antibodies against the measles virus specifically target the hemagglutinin and fusion glycoproteins, providing a basis for understanding immune protection.
May inform measles vaccine antigen selection; leaves open durability and cellular immunity roles pending trials.
Co-evolving mechanisms of immune clearance and of immune suppression are among the hallmarks of measles. B cells are major targets cells of measles virus (MV) infection. Virus interactions with B cells result both in immune suppression and a vigorous antibody response. Although antibodies fully protect against (re)infection, their importance during the disease and in the presence of a potent cellular response is less well understood. Specific serum IgM appears with onset of rash and confirms clinical diagnosis. After isotype switching, IgG1 develops and confers life-long protection. The most abundant antibodies are specific for the nucleoprotein, but neutralizing and protective antibodies are solely directed against the two surface glycoproteins, the hemagglutinin and the fusion protein. Major neutralizing epitopes have been mapped mainly on the hemagglutinin protein with monoclonal antibodies, producing an increasingly comprehensive map of functional domains.
No takes yet. Share an insight, caveat, or question.
Bouche et al. (2002) conducted a review in Measles. Neutralizing and protective antibodies in measles are solely directed against the two surface glycoproteins, hemagglutinin and fusion protein.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: